Replek
1945
FOUNDED
PUBLIC
STATUS
401-500
EMPLOYEES
REPL
STOCK SYMBOL
$1.42K
SHARE PRICE
(As of Monday Closing)
Description
Replek AD is engaged in the development, design and production of generic medicines. The company develops drugs in different pharmaceutical therapeutic categories including anti-platelet, lipid-lowering, atypical antipsychotic, anti-infective, among others. It manufactures drugs in different forms including tablets, capsules, oral solutions, creams and ointments. Its product portfolio consists of Clopidogrel, Atorvastatin, Simvastatin, risperidone, Clarythromycin, Ciprofloxacin, Meloksikam, Risperidon, terazosin, among others. Replek also offers cannabis oil products, food supplements and cosmetics.
Primary Industry
Pharmaceuticals
Other Industries
Distributors/Wholesale
Other Devices and Supplies
Stock Exchange
XMAE
Primary Office
- Kozle st. 188
- Skopje, 1000
- Macedonia
+389 02 000 0000
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Replek’s full profile, request a free trial.
Replek Stock Performance
| 52 wk Range | Market Cap | Prev. Close | EPS | Average Volume | Shares |
|---|---|---|---|---|---|
| $1.31K - $1.42K | $1.41K | 18.43 |
Replek Financials Summary
|
In Thousands,
USD |
TTM
30-Sep-2018
|
FY 2017
31-Dec-2017
|
FY 2016
31-Dec-2016
|
FY 2015
31-Dec-2015
|
|---|---|---|---|---|
| Enterprise Value | 32,317 | 26,858 | 19,416 | 18,679 |
| Revenue | 19,490 | 17,364 | 14,768 | 14,500 |
| EBITDA | 2,865 | 2,691 | 2,222 | 1,900 |
| Net Income | 2,465 | 2,348 | 1,939 | 1,649 |
| Total Assets | 34,809 | 29,954 | 30,332 | |
| Total Debt | 0 | 1,218 | 1,567 | 1,174 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer